OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Developments in Vaccine Adjuvants
Farrhana Ziana Firdaus, Mariusz Skwarczyński, István Tóth
Methods in molecular biology (2021), pp. 145-178
Closed Access | Times Cited: 74
Farrhana Ziana Firdaus, Mariusz Skwarczyński, István Tóth
Methods in molecular biology (2021), pp. 145-178
Closed Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Recent Developments in Metallic Nanomaterials for Cancer Therapy, Diagnosing and Imaging Applications
Dan Nicolae Păduraru, Daniel Ion, Adelina-Gabriela Niculescu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 435-435
Open Access | Times Cited: 71
Dan Nicolae Păduraru, Daniel Ion, Adelina-Gabriela Niculescu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 435-435
Open Access | Times Cited: 71
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses
Shirin Mahmoodi, Javad Zamani Amirzakaria, Abdolmajid Ghasemian
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285177-e0285177
Open Access | Times Cited: 29
Shirin Mahmoodi, Javad Zamani Amirzakaria, Abdolmajid Ghasemian
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285177-e0285177
Open Access | Times Cited: 29
Research progress on emulsion vaccine adjuvants
Zhuanqing Huang, Hui Gong, Qi Sun, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24662-e24662
Open Access | Times Cited: 13
Zhuanqing Huang, Hui Gong, Qi Sun, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24662-e24662
Open Access | Times Cited: 13
Vaccine adjuvants: current status, research and development, licensing, and future opportunities
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 10
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 10
A Mn2+‐Assisted Nanofiber‐Hydrogel Adjuvant for Simultaneous Enhancement of Humoral and Cellular Immune Responses
Haixue Jia, Lin Jia, Dianyu Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 8
Haixue Jia, Lin Jia, Dianyu Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 8
Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant
Viet Tram Duong, Mariusz Skwarczyński, István Tóth
Tuberculosis (2023) Vol. 139, pp. 102307-102307
Closed Access | Times Cited: 19
Viet Tram Duong, Mariusz Skwarczyński, István Tóth
Tuberculosis (2023) Vol. 139, pp. 102307-102307
Closed Access | Times Cited: 19
In Silico Studies to Support Vaccine Development
Leonor Saldanha, Ülo Langel, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 654-654
Open Access | Times Cited: 16
Leonor Saldanha, Ülo Langel, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 654-654
Open Access | Times Cited: 16
Toward innovative veterinary nanoparticle vaccines
Meiqi Sun, Aldryan Cristianto Pratama, Qiu He, et al.
Animal Diseases (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 6
Meiqi Sun, Aldryan Cristianto Pratama, Qiu He, et al.
Animal Diseases (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 6
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 6
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 6
Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines
Hang Zhang, Qin Luo, Yingxin He, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 8, pp. 491-491
Open Access | Times Cited: 15
Hang Zhang, Qin Luo, Yingxin He, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 8, pp. 491-491
Open Access | Times Cited: 15
Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
K. Devaraja, Sadhna Aggarwal, Manisha Singh
Vaccines (2023) Vol. 11, Iss. 3, pp. 634-634
Open Access | Times Cited: 14
K. Devaraja, Sadhna Aggarwal, Manisha Singh
Vaccines (2023) Vol. 11, Iss. 3, pp. 634-634
Open Access | Times Cited: 14
A review on the development of bacterial multi-epitope recombinant protein vaccines via reverse vaccinology
Yuxin Li, Muhammad Haris Raza Farhan, Xiaohan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136827-136827
Closed Access | Times Cited: 5
Yuxin Li, Muhammad Haris Raza Farhan, Xiaohan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136827-136827
Closed Access | Times Cited: 5
Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens
Sudeep Kumar, Karsten R. O. Hazlett, Guangchun Bai
Vaccine (2025) Vol. 48, pp. 126729-126729
Closed Access
Sudeep Kumar, Karsten R. O. Hazlett, Guangchun Bai
Vaccine (2025) Vol. 48, pp. 126729-126729
Closed Access
Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes
Emmanuel Dollinger, Jenny E. Hernandez‐Davies, Jiin Felgner, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
Emmanuel Dollinger, Jenny E. Hernandez‐Davies, Jiin Felgner, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
Metal nanoparticles and sensitivity/resistance to therapy in cancer: two sides of the coin?
Atena Abed, Seyed Abbas Mirzaei, Sayedeh Azimeh Hosseini, et al.
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 2
Closed Access
Atena Abed, Seyed Abbas Mirzaei, Sayedeh Azimeh Hosseini, et al.
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 2
Closed Access
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 20
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 20
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection
Dan Zhou, Rao Cheng, Yanfeng Yao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Dan Zhou, Rao Cheng, Yanfeng Yao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Application prospect of polysaccharide in the development of vaccine adjuvants
Lei Feng, Jiarui Zhang, Chunyan Ma, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139845-139845
Closed Access
Lei Feng, Jiarui Zhang, Chunyan Ma, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139845-139845
Closed Access
Progress in African Swine Fever Vector Vaccine Development
Yue Yang, Hengxing Yuan, Yulu Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 921-921
Open Access
Yue Yang, Hengxing Yuan, Yulu Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 921-921
Open Access
Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection
Mirian França de Mello, Patrícia de Almeida Machado, Pollyane Sousa Gomes, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 129-129
Open Access
Mirian França de Mello, Patrícia de Almeida Machado, Pollyane Sousa Gomes, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 129-129
Open Access
Influence of component structural arrangement on cholesterol-antigen conjugate immunogenicity and antisera bactericidal activity against group A Streptococcus
Mariusz Skwarczyński, Nedaa Alharbi, Ummey Jannatun Nahar, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108248-108248
Open Access
Mariusz Skwarczyński, Nedaa Alharbi, Ummey Jannatun Nahar, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108248-108248
Open Access
An Injectable Chitosan Hydrochloride-Sodium Alginate Hydrogel Adjuvant Capable of Eliciting Potent Humoral and Cellular Immunity
Yonghao Lai, Sibo Wang, Xiwen Shen, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 14444-14459
Closed Access
Yonghao Lai, Sibo Wang, Xiwen Shen, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 14444-14459
Closed Access
Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
Juan Shi, Zhao Yu, Min Peng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 713-713
Open Access | Times Cited: 10
Juan Shi, Zhao Yu, Min Peng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 713-713
Open Access | Times Cited: 10
